Endothelin receptor antagonist exacerbates autoimmune myocarditis in mice

Life Sciences

Volumn 118, Issue 2, 2014, Pages 288-296

  Tajiri, Kazuko ^a   Sakai, Satoshi ^a   Kimura, Taizo ^a   Machino Ohtsuka, Tomoko ^a   Murakoshi, Nobuyuki ^a   Xu, Dongzhu ^a   Wang, Zheng ^a   Sato, Akira ^a   Miyauchi, Takashi ^a   Aonuma, Kazutaka ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Autoimmune myocarditis; Endothelin; Inflammation; Suppressor of cytokine signaling

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; CARDIAC MYOSIN; FREUND ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; CHEMOKINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; MYOSIN; SOCS3 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE EXACERBATION; DRUG EFFECT; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; HEART TO BODY WEIGHT RATIO; HISTOPATHOLOGY; IMMUNIZATION; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; OSMOTIC PUMP; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; TREATMENT DURATION; WEIGHT, MASS AND SIZE; ANIMAL; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICALLY INDUCED; CYTOLOGY; DISEASE COURSE; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; IMMUNOLOGY; LYMPH NODE; METABOLISM; MYOCARDITIS; PATHOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHEMOKINES; DISEASE PROGRESSION; ENDOTHELIN RECEPTOR ANTAGONISTS; ENDOTHELIN-1; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; LYMPH NODES; MICE, INBRED BALB C; MYOCARDITIS; MYOCARDIUM; MYOSINS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84942613260     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.01.007     Document Type: Article

References (32)

1. Barton, M., Haudenschild, C.C., d'Uscio, L.V., Shaw, S., Munter, K., Luscher, T.F., Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 95 (1998), 14367–14372.
2. Bergelson, J.M., Cunningham, J.A., Droguett, G., Kurt-Jones, E.A., Krithivas, A., Hong, J.S., et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275 (1997), 1320–1323.
3. Chang, H.H., Huang, Y.M., Wu, C.P., Tang, Y.C., Liu, C.W., Huang, C.H., et al. Endothelin-1 stimulates suppressor of cytokine signaling-3 gene expression in adipocytes. Gen Comp Endocrinol 178 (2012), 450–458.
4. Croker, B.A., Kiu, H., Nicholson, S.E., SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 19 (2008), 414–422.
5. Dimitriou, I.D., Clemenza, L., Scotter, A.J., Chen, G., Guerra, F.M., Rottapel, R., Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 224 (2008), 265–283.
6. Eriksson, U., Ricci, R., Hunziker, L., Kurrer, M.O., Oudit, G.Y., Watts, T.H., et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9 (2003), 1484–1490.
7. Fairweather, D., Kaya, Z., Shellam, G.R., Lawson, C.M., Rose, N.R., From infection to autoimmunity. J Autoimmun 16 (2001), 175–186.
8. Ghoreschi, K., Laurence, A., Yang, X.P., Hirahara, K., O'Shea, J.J., T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol 32 (2011), 395–401.
9. Gretz, J.E., Anderson, A.O., Shaw, S., Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol Rev 156 (1997), 11–24.
10. Itano, A.A., Jenkins, M.K., Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol 4 (2003), 733–739.
11. Kindermann, I., Barth, C., Mahfoud, F., Ukena, C., Lenski, M., Yilmaz, A., et al. Update on myocarditis. J Am Coll Cardiol 59 (2012), 779–792.
12. Lazzerini, P.E., Capecchi, P.L., Laghi-Pasini, F., Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy: editorial to “pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice” by K. Tajiri et al. Cardiovasc Drugs Ther 27 (2013), 365–369.
13. Lehtimaki, S., Lahesmaa, R., Regulatory T cells control immune responses through their non-redundant tissue specific features. Front Immunol, 4, 2013, 294.
14. Leuschner, F., Katus, H.A., Kaya, Z., Autoimmune myocarditis: past, present and future. J Autoimmun 33 (2009), 282–289.
15. Li, Y., Chu, N., Rostami, A., Zhang, G.X., Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 177 (2006), 1679–1688.
16. Maki, S., Miyauchi, T., Kakinuma, Y., Sakai, S., Kobayashi, T., Sugiyama, F., et al. The endothelin receptor antagonist ameliorates the hypertensive phenotypes of transgenic hypertensive mice with renin–angiotensin genes and discloses roles of organ specific activation of endothelin system in transgenic mice. Life Sci 74 (2004), 1105–1118.
17. Marchant, D., Dou, Y., Luo, H., Garmaroudi, F.S., McDonough, J.E., Si, X., et al. Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during Coxsackievirus-induced myocarditis. Circ Res 104 (2009), 813–821.
18. Murakoshi, N., Miyauchi, T., Kakinuma, Y., Ohuchi, T., Goto, K., Yanagisawa, M., et al. Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice. Circulation 106 (2002), 1991–1998.
19. Ono, K., Matsumori, A., Shioi, T., Furukawa, Y., Sasayama, S., Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: acute effects of bosentan, an endothelin receptor antagonist. Circulation 100 (1999), 1823–1829.
20. Qin, H., Yeh, W.I., De Sarno, P., Holdbrooks, A.T., Liu, Y., Muldowney, M.T., et al. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proc Natl Acad Sci U S A 109 (2012), 5004–5009.
21. Sakai, S., Miyauchi, T., Kobayashi, M., Yamaguchi, I., Goto, K., Sugishita, Y., Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384 (1996), 353–355.
22. Seta, Y., Kanda, T., Yokoyama, T., Arai, M., Sekiguchi, K., Tanaka, T., et al. Therapy with the nonpeptide endothelin receptor antagonist 97–139 in a murine model of congestive heart failure: reduction of cardiac mass and myofiber hypertrophy. Jpn Heart J 41 (2000), 79–85.
23. Shevach, E.M., DiPaolo, R.A., Andersson, J., Zhao, D.M., Stephens, G.L., Thornton, A.M., The lifestyle of naturally occurring CD4 + CD25 + Foxp3 + regulatory T cells. Immunol Rev 212 (2006), 60–73.
24. Shuai, K., Liu, B., Regulation of JAK–STAT signalling in the immune system. Nat Rev Immunol 3 (2003), 900–911.
25. Sonderegger, I., Iezzi, G., Maier, R., Schmitz, N., Kurrer, M., Kopf, M., GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J Exp Med 205 (2008), 2281–2294.
26. Stewart, D.J., Kubac, G., Costello, K.B., Cernacek, P., Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 18 (1991), 38–43.
27. Tajiri, K., Imanaka-Yoshida, K., Matsubara, A., Tsujimura, Y., Hiroe, M., Naka, T., et al. Suppressor of cytokine signaling 1 DNA administration inhibits inflammatory and pathogenic responses in autoimmune myocarditis. J Immunol 189 (2012), 2043–2053.
28. Tajiri, K., Shimojo, N., Sakai, S., Machino-Ohtsuka, T., Imanaka-Yoshida, K., Hiroe, M., et al. Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice. Cardiovasc Drugs Ther 27 (2013), 413–424.
29. Valaperti, A., Marty, R.R., Kania, G., Germano, D., Mauermann, N., Dirnhofer, S., et al. CD11b + monocytes abrogate Th17 CD4 + T cell-mediated experimental autoimmune myocarditis. J Immunol 180 (2008), 2686–2695.
30. Yajima, T., Murofushi, Y., Zhou, H., Park, S., Housman, J., Zhong, Z.H., et al. Absence of SOCS3 in the cardiomyocyte increases mortality in a gp130-dependent manner accompanied by contractile dysfunction and ventricular arrhythmias. Circulation 124 (2011), 2690–2701.
31. Yoshimura, A., Naka, T., Kubo, M., SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7 (2007), 454–465.
32. Zheng, Y., Rudensky, A.Y., Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8 (2007), 457–462.